Results 121 to 130 of about 921,945 (165)

Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR). [PDF]

Ann Hematol
Gunduz E, Ulas T, Ozkalemkas F, Toprak SK, Karakulak EA, Ar MC, Gulbas Z, Ozkocaman V, Aydogan M, Buyukasik Y, Cerme MDO, Mehtap O, Kucur D, Kaya E, Yavasoglu I, Besisik SK, Ersal T, Yuksel M, Hacioglu S, Hacibekiroglu T, Kaya A, Sakci E, Yuksel MK, Ozet G, Cagliyan GA, Hasanzade U, Salim O, Pepeler MS, Turgut M, Kurekci DD, Giden AO, Sener S, Calika S, Dal MS.   +33 more
europepmc   +1 more source

Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes. [PDF]

Ann Hematol
Negishi S, Miyao K, Ohara F, Motegi K, Wakabayashi H, Sawa H, Inagaki Y, Sawa M.   +7 more
europepmc   +1 more source

Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial. [PDF]

Br J Haematol
Nakamura F, Ishiyama K, Suzuki R, Maruyama H, Onishi Y, Usuki K, Koh H, Takenaka K, Saiki R, Ogawa S, Matsumoto K, Takahashi T, Hosomichi K, Zaimoku Y, Yoshimura K, Matsumura I, Akashi K, Nakao S.   +17 more
europepmc   +1 more source

External Validation of the Kidney Donor Profile Index to Predict Long-Term Graft Survival in Kidney Transplant Recipients. [PDF]

Kidney360
Cassão B, Foresto RD, Hazin MA, Morais AP, de Andrade LGM, Medina-Pestana J, Requião-Moura L, Tedesco-Silva H.   +7 more
europepmc   +1 more source

Impact of post-transplant cyclophosphamide and anti-thymocyte globulin on immune reconstitution in MUD allo-HCT. [PDF]

Front Immunol
Furnari G, Wais V, Francesio A, Strauss K, Piemontese S, Schnell J, Gianni P, Greco R, Stegelmann F, Ruggeri A, Assanelli A, Bunjes D, Ciceri F, Döhner H, Lupo-Stanghellini MT, Sala E.   +15 more
europepmc   +1 more source

Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party. [PDF]

Bone Marrow Transplant
Bug G, Labopin M, Byrne JL, Mielke S, Orchard K, Paneesha S, Potter V, Blaise D, Besley C, Snowden JA, Yakoub-Agha I, Clark A, Crawley C, Spyridonidis A, Sanz J, Brissot E, Giebel S, Ciceri F, Mohty M.   +18 more
europepmc   +1 more source

Rescued with T and B lymphocytes depletion therapy for immune checkpoint inhibitor-associated transplant rejection. [PDF]

Immunotherapy
Qiu S, Zong Z, He K.
europepmc   +1 more source

Elevated Matrix Metalloproteinase Type 9 (MMP-9) Transcripts After Thymoglobulin Induction in Incident Kidney Transplant Recipients. [PDF]

Int J Mol Sci
Petersen TBB, Nagarajah S, Tepel M.
europepmc   +1 more source

Immunotherapy as rescue for cardiomyopathy in Omenn syndrome. [PDF]

J Hum Immun
Boutinaud S, Barlogis V, Berthomieu L, Sierra Colomina M, Pasquet M.   +4 more
europepmc   +1 more source

A randomized trial of GVHD prophylaxis in haploidentical PBSC transplantation: ATG, PTCy, and low-dose combination therapy.

Blood
Yang J, Jia Y, Hu X, Zhou F, Ni X, Wan J, Ding Y, Kang M, Yu X, Jiang C, Wang L, Wan L, Cai Y, Huang C, Qiu H, Ding X, Tong Y, Dong B, Zhou K, Song X.   +19 more
europepmc   +1 more source